PSIP1 and posterior cortical atrophy: In contrast, an IIF-ANA survey of anti-DFS70/LEDGF autoantibodies, conducted by Bizzaro et al. [141] in 334 cancer patients representing 27 different malignancies, revealed a low frequency of these antibodies (1.8% overall in cancer, 2% in 48 PCa).